These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9199010)

  • 1. [Evidence-based medicine and disseminated intravascular coagulation (DIC)].
    Skadborg MK
    Ugeskr Laeger; 1997 May; 159(21):3189-90. PubMed ID: 9199010
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antithrombin III in the treatment of disseminated intravascular coagulation].
    Nordgaard-Andersen I; Madsen JR
    Ugeskr Laeger; 1997 Feb; 159(6):730-1. PubMed ID: 9045459
    [No Abstract]   [Full Text] [Related]  

  • 3. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
    Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
    Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
    Takahashi K
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
    [No Abstract]   [Full Text] [Related]  

  • 5. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
    Hanada T; Abe T; Takita H
    Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of anorexia nervosa with disseminated intravascular coagulation syndrome.
    Haruta I; Asakawa A; Ogiso K; Amitani H; Amitani M; Tsai M; Hamada S; Inui A
    Int J Eat Disord; 2012 Apr; 45(3):453-5. PubMed ID: 22407868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary study for the evaluation of the feasibility of a multicenter clinical trial for the evaluation of the therapeutic efficacy of an antithrombin III concentration (Immuno) in the intravascular coagulation syndrome].
    Palareti G; Legnani C; Ludovici S; Maccaferri M
    Haematologica; 1990; 75 Suppl 2():21-32. PubMed ID: 2201605
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disseminated intravascular coagulation in children. Therapeutic problems].
    Fiori GM; Murgia G; Targhetta R; Putzolu G; Biddau P
    Pediatr Med Chir; 1989; 11(5):491-4. PubMed ID: 2698466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparin, low molecular weight heparin, heparinoid, and antithrombin III therapy of disseminated intravascular coagulation].
    Nakagawa M
    Nihon Rinsho; 1993 Jan; 51(1):87-92. PubMed ID: 7679453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
    Sobczyk J; Swietliński J; Podleśny-Owsińska T
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy with antithrombin III concentrate].
    Vinazzer H
    Haematologica; 1990; 75 Suppl 2():14-20. PubMed ID: 2201604
    [No Abstract]   [Full Text] [Related]  

  • 12. Japanese consensus for disseminated intravascular coagulation (DIC): is it a small world after all?
    Levi M
    Thromb Res; 2010 Jan; 125(1):4-5. PubMed ID: 19735937
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment effects of antithrombin-III on coagulation abnormalities in rats with endotoxaemia].
    Qiao YJ; Zhu JM; You XL; Zhang Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):165-7. PubMed ID: 17376272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous administration of antithrombin III and protein C concentrates for the treatment of a devastating coagulopathy in a child.
    Favier R; Deschamps A; Belhocine R; Ankri A; Costil J; de Moerloose P
    Hematol Cell Ther; 1998 Apr; 40(2):67-70. PubMed ID: 9615249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation.
    Vinazzer H
    Semin Thromb Hemost; 1989 Jul; 15(3):347-52. PubMed ID: 2688106
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of antithrombin III (ATIII) for disseminated intravascular coagulation (DIC) during septic shock.
    Cohendy R; Lefrant JY; de la Coussaye JE
    Intensive Care Med; 1998 Dec; 24(12):1344. PubMed ID: 9885894
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
    Jespersen J; Rasmussen NR; Sidelmann J
    Acta Chir Scand Suppl; 1982; 509():105-7. PubMed ID: 6962611
    [No Abstract]   [Full Text] [Related]  

  • 18. The initial experience of antithrombin III in the management of neonates with necrotizing enterocolitis.
    St Peter SD; Little DC; Calkins CM; Holcomb GW; Snyder CL; Ostlie DJ
    J Pediatr Surg; 2007 Apr; 42(4):704-8. PubMed ID: 17448770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin-III concentrate infusion.
    Wisecarver JL; Haire WD
    Thromb Res; 1989 Jun; 54(6):709-17. PubMed ID: 2781511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin III in Sepsis. New evidences and open questions.
    Ostermann H
    Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.